Assessment of Serum and Urine Neurophil Gelatinase- Associated Lipocalin (s-NGAL and u-NGAL) Level as a Predictive Factor of Disease Progression in Diabetic Nephropathy in Type 2 DM
Iranian Journal of Kidney Diseases · 2021
DOI: 10.52547/ijkd.6017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Kidney Diseases, 2021. Verfasst von Atefeh Amouzegar und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Amouzegar, A., Najafi, L., Rajabi, S. K., Pirsaheb, S., Keyvani, H., Khajavi, A., Shati, M., & Hadavand, F. (2021). Assessment of Serum and Urine Neurophil Gelatinase- Associated Lipocalin (s-NGAL and u-NGAL) Level as a Predictive Factor of Disease Progression in Diabetic Nephropathy in Type 2 DM. Iranian Journal of Kidney Diseases. https://doi.org/10.52547/ijkd.6017
Vancouver
Amouzegar A, Najafi L, Rajabi SK, Pirsaheb S, Keyvani H, Khajavi A, et al. Assessment of Serum and Urine Neurophil Gelatinase- Associated Lipocalin (s-NGAL and u-NGAL) Level as a Predictive Factor of Disease Progression in Diabetic Nephropathy in Type 2 DM. Iranian Journal of Kidney Diseases. 2021. doi:10.52547/ijkd.6017
BibTeX
@article{Amouzegar2021,
author = {Amouzegar, Atefeh and Najafi, Laily and Rajabi, Shahin Keshtkar and Pirsaheb, Sondos and Keyvani, Hossein and Khajavi, Alireza and Shati, Mohsen and Hadavand, Fahimeh},
title = {Assessment of Serum and Urine Neurophil Gelatinase- Associated Lipocalin (s-NGAL and u-NGAL) Level as a Predictive Factor of Disease Progression in Diabetic Nephropathy in Type 2 DM},
journal = {Iranian Journal of Kidney Diseases},
year = {2021},
doi = {10.52547/ijkd.6017}
}
EUVIMED